{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:34:28Z","timestamp":1791466468142,"version":"4.3.4"},"reference-count":108,"publisher":"Japan Atherosclerosis Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Atheroscler Thromb","JAT"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5551\/jat.rv17006","type":"journal-article","created":{"date-parts":[[2017,5,26]],"date-time":"2017-05-26T18:06:58Z","timestamp":1495822018000},"page":"660-672","source":"Crossref","is-referenced-by-count":440,"title":["Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?"],"prefix":"10.5551","volume":"24","author":[{"given":"Hideo","family":"Ohira","sequence":"first","affiliation":[{"name":"Division of Clinical Nutrition, Faculty of Nutrition, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wao","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"Division of Clinical Nutrition, Faculty of Nutrition, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Division of Clinical Nutrition, Faculty of Nutrition, Kobe Gakuin University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, Nielsen T, Pons N, Levenez F, Yamada T, Mende DR, Li J, Xu J, Li S, Li D, Cao J, Wang B, Liang H, Zheng H, Xie Y, Tap J, Lepage P, Bertalan M, Batto JM, Hansen T, Le Paslier D, Linneberg A, Nielsen HB, Pelletier E, Renault P, Sicheritz-Ponten T, Turner K, Zhu H, Yu C, Li S, Jian M, Zhou Y, Li Y, Zhang X, Li S, Qin N, Yang H, Wang J, Brunak S, Dor\u00e9 J, Guarner F, Kristiansen K, Pedersen O, Parkhill J, Weissenbach J; Meta-HIT Consortium, Bork P, Ehrlich SD, Wang J: A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 2010; 464: 59-65","DOI":"10.1038\/nature08821"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Lepage P, Leclerc MC, Joossens M, Mondot S, Blotti\u00e8re HM, Raes J, Ehrlich D, Dor\u00e9 J: A metagenomic insight into our gut's microbiome. Gut, 2013; 62: 146-158","DOI":"10.1136\/gutjnl-2011-301805"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Sonnenburg JL, B\u00e4ckhed F: Diet-microbiota interactions as moderators of human metabolism. Nature, 2016; 535: 56-64","DOI":"10.1038\/nature18846"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Cummings JH, Pomare EW, Branch WJ, Naylor CP, Macfarlane GT: Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut, 1987; 28: 1221-1227","DOI":"10.1136\/gut.28.10.1221"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Macfarlane GT, Macfarlane S: Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int, 2012; 95: 50-60","DOI":"10.5740\/jaoacint.SGE_Macfarlane"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL: Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature, 2011; 472: 57-63","DOI":"10.1038\/nature09922"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Karlsson FH, F\u00e5k F, Nookaew I, Tremaroli V, Fagerberg B, Petranovic D, B\u00e4ckhed F, Nielsen J: Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat Commun, 2012; 3: 1245","DOI":"10.1038\/ncomms2266"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Koh A, De Vadder F, Kovatcheva-Datchary P, B\u00e4ckhed F: From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 2016; 165: 1332-1345","DOI":"10.1016\/j.cell.2016.05.041"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Yamashita T: Intestinal immunity and gut microbeta in Atherosclerosis. J Atheroscler Thromb, 2017; 24: 110-119","DOI":"10.5551\/jat.38265"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Kasabuchi M, Hasegawa S, Hiramatsu T, Ichimura A, Kimura I: Dietary gut microbial metabolites, short-chain fatty acids, and host metabolic regulation. Nutrients, 2015; 7: 2839-2849","DOI":"10.3390\/nu7042839"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tang WH, Hazen SL: The contributory role of gut microbeta in cardiovascular disease. J Clin Invest, 2014; 124: 4204-4211","DOI":"10.1172\/JCI72331"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Louis P, Hold GL, Flint HJ: The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol, 2014; 12: 661-672","DOI":"10.1038\/nrmicro3344"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Rey FE, Faith JJ, Bain J, Muehlbauer MJ, Stevens RD, Newgard CB, Gordon JI: Dissecting the in vivo metabolic potential of two human gut acetogens. J Biol Chem, 2010; 285: 22082-22090","DOI":"10.1074\/jbc.M110.117713"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Scott KP, Martin JC, Campbell G, Mayer CD, Flint HJ: Whole-genome transcription profiling reveals genes upregulated by growth on fucose in the human gut bacterium \u201cRoseburia inulinivorans\u201d. J Bacteriol, 2006; 188: 4340-4349","DOI":"10.1128\/JB.00137-06"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Duncan SH, Barcenilla A, Stewart CS, Pryde SE, Flint HJ: Acetate utilization and butyryl coenzyme A (CoA):acetate-CoA transferase in butyrate-producing bacteria from the human large intestine. Appl Environ Microbiol, 2002; 68: 5186-5190","DOI":"10.1128\/AEM.68.10.5186-5190.2002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S: Host-gut microbiota metabolic interactions. Science, 2012; 336: 1262-1267","DOI":"10.1126\/science.1223813"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ: Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol, 2006; 40: 235-243","DOI":"10.1097\/00004836-200603000-00015"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Bergman EN: Energy contributions of volatile fatty acids from the gastrointestinal tract in various species. Physiol Rev, 1990; 70: 567-590","DOI":"10.1152\/physrev.1990.70.2.567"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Verbeke KA, Boobis AR, Chiodini A, Edwards CA, Franck A, Kleerebezem M, Nauta A, Raes J, van Tol EA, Tuohy KM: Towards microbial fermentation metabolites as markers for health benefits of prebiotics. Nutr Res Rev, 2015; 28: 42-66","DOI":"10.1017\/S0954422415000037"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Whelan K, Judd PA, Preedy VR, Simmering R, Jann A, Taylor MA: Fructooligosaccharides and fiber partially prevent the alterations in fecal microbiota and shortchain fatty acid concentrations caused by standard enteral formula in healthy humans. J Nutr, 2005; 135: 1896-1902","DOI":"10.1093\/jn\/135.8.1896"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Boler BM, Serao MC, Bauer LL, Staeger MA, Boileau TW, Swanson KS, Fahey GC Jr: Digestive physiological outcomes related to polydextrose and soluble maize fibre consumption by healthy adult men. Br J Nutr, 2011; 106: 1864-1871","DOI":"10.1017\/S0007114511002388"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Lewis SJ, Heaton KW: Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut, 1997; 41: 245-251","DOI":"10.1136\/gut.41.2.245"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Lecerf JM, D\u00e9peint F, Clerc E, Dugenet Y, Niamba CN, Rhazi L, Cayzeele A, Abdelnour G, Jaruga A, Younes H, Jacobs H, Lambrey G, Abdelnour AM, Pouillart PR: Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr, 2012; 108: 1847-1858","DOI":"10.1017\/S0007114511007252"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Reimer RA, Pelletier X, Carabin IG, Lyon MR, Gahler RJ, Wood S: Faecal short chain fatty acids in healthy subjects participating in a randomised controlled trial examining a soluble highly viscous polysaccharide versus control. J Hum Nutr Diet, 2012; 25: 373-377","DOI":"10.1111\/j.1365-277X.2012.01230.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Fernando WM, Hill JE, Zello GA, Tyler RT, Dahl WJ, Van Kessel AG: Diets supplemented with chickpea or its main oligosaccharide component raffinose modify faecal microbial composition in healthy adults. Benef Microbes, 2010; 1: 197-207","DOI":"10.3920\/BM2009.0027"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) McOrist AL, Miller RB, Bird AR, Keogh JB, Noakes M, Topping DL, Conlon MA: Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch. J Nutr, 2011; 141: 883-889","DOI":"10.3945\/jn.110.128504"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nemoto H, Kataoka K, Ishikawa H, Ikata K, Arimochi H, Iwasaki T, Ohnishi Y, Kuwahara T, Yasutomo K: Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis. Dig Dis Sci, 2012; 57: 2955-2964","DOI":"10.1007\/s10620-012-2236-y"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Tiihonen K, Ouwehand AC, Rautonen N: Effect of overweight on gastrointestinal microbiology and immunology: correlation with blood biomarkers. Br J Nutr, 2010; 103: 1070-1078","DOI":"10.1017\/S0007114509992807"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) McOrist AL, Abell GC, Cooke C, Nyland K: Bacterial population dynamics and faecal short-chain fatty acid (SCFA) concentrations in healthy humans. Br J Nutr, 2008; 100: 138-146","DOI":"10.1017\/S0007114507886351"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Hylla S, Gostner A, Dusel G, Anger H, Bartram HP, Christl SU, Kasper H, Scheppach W: Effects of resistant starch on the colon in healthy volunteers: possible implications for cancerprevention. Am J Clin Nutr, 1998; 67: 136-142","DOI":"10.1093\/ajcn\/67.1.136"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Schwiertz A, Taras D, Sch\u00e4fer K, Beijer S, Bos NA, Donus C, Hardt PD: Microbiota and SCFA in lean and overweight healthy subjects. Obesity, 2010; 18: 190-195","DOI":"10.1038\/oby.2009.167"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Brinkworth GD, Noakes M, Clifton PM, Bird AR: Comparative effects of very low-carbohydrate, high-fat and high-carbohydrate, low-fat weight-loss diets on bowel habit and faecal short-chain fatty acids and bacterial populations. Br J Nutr, 2009; 101: 1493-1502","DOI":"10.1017\/S0007114508094658"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Benassi-Evans B, Clifton P, Noakes M, Fenech M: High-protein\/high red meat and high-carbohydrate weightloss diets do not differ in their effect on faecal water genotoxicity tested by use of the WIL2-NS cell line and with other biomarkers of bowel health. Mutat Res, 2010; 703: 130-136","DOI":"10.1016\/j.mrgentox.2010.08.009"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Dankert J, Zijlstra JB, Wolthers BG: Volatile fatty acids in human peripheral and portal blood: quantitative determination vacuum distillation and gas chromatography. Clin Chim Acta, 1981; 110: 301-307","DOI":"10.1016\/0009-8981(81)90359-4"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Peters SG, Pomare EW, Fisher CA: Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut, 1992; 33: 1249- 1252","DOI":"10.1136\/gut.33.9.1249"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) van der Beek CM, Bloemen JG, van den Broek MA, Lenaerts K, Venema K, Buurman WA, Dejong CH: Hepatic Uptake of Rectally Administered Butyrate Prevents an Increase in Systemic Butyrate Concentrations in Humans. J Nutr, 2015; 145: 2019-2024","DOI":"10.3945\/jn.115.211193"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Jakobsdottir G, J\u00e4dert C, Holm L, Nyman ME: Propionic and butyric acids, formed in the caecum of rats fed highly fermentable dietary fibre, are reflected in portal and aortic serum. Br J Nutr, 2013; 110: 1565-1572","DOI":"10.1017\/S0007114513000809"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Miyoshi M, Sakaki H, Usami M, Iizuka N, Shuno K, Aoyama M, Usami Y: Oral administration of tributyrin increases concentration of butyrate in the portal vein and prevents lipopolysaccharide-induced liver injury in rats. Clin Nutr, 2011; 30: 252-258","DOI":"10.1016\/j.clnu.2010.09.012"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Stoddart LA, Smith NJ, Milligan G: International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol Rev, 2008; 60: 405-417","DOI":"10.1124\/pr.108.00802"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Le Poul E, Loison C, Struyf S, Springael JY, Lannoy V, Decobecq ME, Brezillon S, Dupriez V, Vassart G, Van Damme J, Parmentier M, Detheux M: Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J Biol Chem, 2003; 278: 25481-25489","DOI":"10.1074\/jbc.M301403200"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, HammerRE, Williams SC, Crowley J, Yanagisawa M, Gordon JI: Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A, 2008; 105: 16767-16772","DOI":"10.1073\/pnas.0808567105"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Ge H, Li X, Weiszmann J, Wang P, Baribault H, Chen JL, Tian H, Li Y: Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids. Endocrinology, 2008; 149: 4519-4526","DOI":"10.1210\/en.2008-0059"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Tunaru S, Kero J, Schaub A, Wufka C, Blaukat A, Pfeffer K, Offermanns S: PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med, 2003; 9: 352-355","DOI":"10.1038\/nm824"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Taggart AK, Kero J, Gan X, Cai TQ, Cheng K, Ippolito M, Ren N, Kaplan R, Wu K, Wu TJ, Jin L, Liaw C, Chen R, Richman J, Connolly D, Offermanns S, Wright SD, Waters MG: (D)-beta-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem, 2005; 280: 26649-26652","DOI":"10.1074\/jbc.C500213200"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, Lee JR, Offermanns S, Ganapathy V: Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity, 2014; 40: 128-139","DOI":"10.1016\/j.immuni.2013.12.007"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Feingold KR, Moser A, Shigenaga JK, Grunfeld C: Inflammation stimulates niacin receptor (GPR109A\/ HCA2) expression in adipose tissue and macrophages. J Lipid Res, 2014; 55: 2501-2508","DOI":"10.1194\/jlr.M050955"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Fleischer J, Bumbalo R, Bautze V, Strotmann J, Breer H: Expression of odorant receptor Olfr78 in enteroendo crine cells of the colon. Cell Tissue Res, 2015; 361: 697-710","DOI":"10.1007\/s00441-015-2165-0"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Pluznick J: A novel SCFA receptor, the microbiota, and blood pressure regulation. Gut Microbes, 2014; 5: 202-207","DOI":"10.4161\/gmic.27492"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Belkaid Y, Hand TW: Role of the microbiota in immunity and inflammation. Cell, 2014; 157: 121-141","DOI":"10.1016\/j.cell.2014.03.011"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Curi R, Bond JA, Calder PC, Newsholme EA: Propionate regulates lymphocyte proliferation and metabolism. Gen Pharmacol, 1993; 24: 591-597","DOI":"10.1016\/0306-3623(93)90216-K"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Maier E, Kurz K, Jenny M, Schennach H, Ueberall F, Fuchs D: Food preservatives sodium benzoate and propionic acid and colorant curcumin suppress Th1-type immune response in vitro. Food Chem Toxicol, 2010; 48: 1950-1956","DOI":"10.1016\/j.fct.2010.04.042"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Bail\u00f3n E, Cueto-Sola M, Utrilla P, Rodr\u00edguez-Cabezas ME, Garrido-Mesa N, Zarzuelo A, Xaus J, G\u00e1lvez J, Comalada M: Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. Immunobiology, 2010; 215: 863-873","DOI":"10.1016\/j.imbio.2010.01.001"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ: Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med, 2014; 20: 159-166","DOI":"10.1038\/nm.3444"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Felice C, Lewis A, Armuzzi A, Lindsay JO, Silver A: Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases. Aliment Pharmacol Ther, 2015; 41: 26-38","DOI":"10.1111\/apt.13008"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, Liu H, Cross JR, Pfeffer K, Coffer PJ, Rudensky AY: Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature, 2013; 504: 451-455","DOI":"10.1038\/nature12726"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Park J, Kim M, Kang SG, Jannasch AH, Cooper B, Patterson J, Kim CH: Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway. Mucosal Immunol, 2015; 8: 80-93","DOI":"10.1038\/mi.2014.44"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Zimmerman MA, Singh N, Martin PM, Thangaraju M, Ganapathy V, Waller JL, Shi H, Robertson KD, Munn DH, Liu K: Butyrate suppresses colonic inflammation through HDAC1-dependent Fas upregulation and Fasmediated apoptosis of T cells. Am J Physiol Gastrointest Liver Physiol, 2012; 302: G1405-15","DOI":"10.1152\/ajpgi.00543.2011"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, Nakanishi Y, Uetake C, Kato K, Kato T, Takahashi M, Fukuda NN, Murakami S, Miyauchi E, Hino S, Atarashi K, Onawa S, Fujimura Y, Lockett T, Clarke JM, Topping DL, Tomita M, Hori S, Ohara O, Morita T, Koseki H, Kikuchi J, Honda K, Hase K, Ohno H: Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 2013; 504: 446-450","DOI":"10.1038\/nature12721"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, Glickman JN, Garrett WS: The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science, 2013; 341: 569-573","DOI":"10.1126\/science.1241165"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Berndt BE, Zhang M, Owyang SY, Cole TS, Wang TW, Luther J, Veniaminova NA, Merchant JL, Chen CC, Huffnagle GB, Kao JY: Butyrate increases IL-23 production by stimulated dendritic cells. Am J Physiol Gastrointest Liver Physiol, 2012; 303: G1384-92","DOI":"10.1152\/ajpgi.00540.2011"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Sasaki N, Yamashita T, Takeda M, Shinohara M, Nakajima K, Tawa H, Usui T, Hirata K: Oral anti-CD3 anti body treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice. Circulation, 2009; 120: 1996-2005","DOI":"10.1161\/CIRCULATIONAHA.109.863431"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Li MO, Rudensky AY: T cell receptor signalling in the control of regulatory T cell differentiation and function. Nat Rev Immunol, 2016; 16: 220-233","DOI":"10.1038\/nri.2016.26"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Vinolo MA, Ferguson GJ, Kulkarni S, Damoulakis G, Anderson K, Bohlooly-Y M, Stephens L, Hawkins PT, Curi R: SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor. PLoS One, 2011; 6: e21205","DOI":"10.1371\/journal.pone.0021205"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R: Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem, 2011; 22: 849-855","DOI":"10.1016\/j.jnutbio.2010.07.009"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Corr\u00eaa-Oliveira R, Fachi JL, Vieira A, Sato FT, Vinolo MA: Regulation of immune cell function by short-chain fatty acids. Clin Transl Immunology, 2016; 5: e73","DOI":"10.1038\/cti.2016.17"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Mirmonsef P, Zariffard MR, Gilbert D, Makinde H, Landay AL, Spear GT: Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands. Am J Reprod Immunol, 2012; 67: 391-400","DOI":"10.1111\/j.1600-0897.2011.01089.x"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR: Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature, 2009; 461: 1282-1286","DOI":"10.1038\/nature08530"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Aoyama M, Kotani J, Usami M: Butyrate and propionate induced activated or non-activated neutrophil apoptosis via HDAC inhibitor activity but without activating GPR-41\/GPR-43 pathways. Nutrition, 2010; 26: 653-661","DOI":"10.1016\/j.nut.2009.07.006"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Rodrigues HG, Takeo Sato F, Curi R, Vinolo MA: Fatty acids as modulators of neutrophil recruitment, function and survival. Eur J Pharmacol, 2016; 785: 50-58","DOI":"10.1016\/j.ejphar.2015.03.098"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Cox MA, Jackson J, Stanton M, Rojas-Triana A, Bober L, Laverty M, Yang X, Zhu F, Liu J, Wang S, Monsma F, Vassileva G, Maguire M, Gustafson E, Bayne M, Chou CC, Lundell D, Jenh CH: Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E(2) and cytokines. World J Gastroenterol, 2009; 15: 5549-5557","DOI":"10.3748\/wjg.15.5549"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Perez R, Stevenson F, Johnson J, Morgan M, Erickson K, Hubbard NE, Morand L, Rudich S, Katznelson S, German JB: Sodium butyrate upregulates Kupffer cell PGE2 production and modulates immune function. J Surg Res, 1998; 78: 1-6","DOI":"10.1006\/jsre.1998.5316"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Usami M, Kishimoto K, Ohata A, Miyoshi M, Aoyama M, Fueda Y, Kotani J: Butyrate and trichostatin A attenuate nuclear factor kappaB activation and tumor necrosis factor alpha secretion and increase prostaglandin E2 secretion in human peripheral blood mononuclear cells. Nutr Res, 2008; 28: 321-328","DOI":"10.1016\/j.nutres.2008.02.012"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Ohira H, Tsutsui W, Mamoto R, Yamaguchi S, Nishida M, Ito M, Fujioka Y: Butyrate attenuates lipolysis in adipocytes co-cultured with macrophages through nonprostaglandin E2-mediated and prostaglandin E2-mediated pathways. Lipids Health Dis, 2016; 15: 213","DOI":"10.1186\/s12944-016-0387-0"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Ohira H, Fujioka Y, Katagiri C, Yano M, Mamoto R, Aoyama M, Usami M, Ikeda M: Butyrate enhancement of inteleukin-1\u03b2 production via activation of oxidative stress pathways in lipopolysaccharide-stimulated THP-1 cells. J Clin Biochem Nutr, 2012; 50: 59-66","DOI":"10.3164\/jcbn.11-22"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL: Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med, 2013; 368: 1575-1584","DOI":"10.1056\/NEJMoa1109400"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Li XS, Obeid S, Klingenberg R, Gencer B, Mach F, R\u00e4ber L, Windecker S, Rodondi N, Nanchen D, Muller O, Miranda MX, Matter CM, Wu Y, Li L, Wang Z, Alamri HS, Gogonea V, Chung YM, Tang WH, Hazen SL, L\u00fcscher TF: Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J, 2017; 38: 814-824","DOI":"10.1093\/eurheartj\/ehw582"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Aguilar EC, Leonel AJ, Teixeira LG, Silva AR, Silva JF, Pelaez JM, Capettini LS, Lemos VS, Santos RA, Alvarez-Leite JI: Butyrate impairs atherogenesis by reducing plaque inflammation and vulnerability and decreasing NF\u03baB activation. Nutr Metab Cardiovasc Dis, 2014; 24: 606-613","DOI":"10.1016\/j.numecd.2014.01.002"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Aguilar EC, Santos LC, Leonel AJ, de Oliveira JS, Santos EA, Navia-Pelaez JM, da Silva JF, Mendes BP, Capettini LS, Teixeira LG, Lemos VS, Alvarez-Leite JI: Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism involving NADPH oxidase downregulation in endothelial cells. J Nutr Biochem, 2016; 34: 99-105","DOI":"10.1016\/j.jnutbio.2016.05.002"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Kasahara K, Tanoue T, Yamashita T, Yodoi K, Matsumoto T, Emoto T, Mizoguchi T, Hayashi T, Kitano N, Sasaki N, Atarashi K, Honda K, Hirata KI: Commensal bacteria at the crossroad between cholesterol homeostasis and chronic inflamemation in Atherosclerosis. J Lipid Res, 2017; 58: 519-528","DOI":"10.1194\/jlr.M072165"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Ryan PM, London LE, Bjorndahl TC, Mandal R, Murphy K, Fitzgerald GF, Shanahan F, Ross RP, Wishart DS, Caplice NM, Stanton C: Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E-\/- mice. Microbiome, 2017; 5: 30. doi: 10.1186\/s40168-017-0246-x","DOI":"10.1186\/s40168-017-0246-x"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Emoto T, Yamashita T, Sasaki N, Hirota Y, Hayashi T, So A, Kasahara K, Yodoi K, Matsumoto T, Mizoguchi T, Ogawa W, Hirata K: Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease. J Atheroscler Thromb, 2016; 23: 908-921","DOI":"10.5551\/jat.32672"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Emoto T, Yamashita T, Kobayashi T, Sasaki N, Hirota Y, Hayashi T, So A, Kasahara K, Yodoi K, Matsumoto T, Mizoguchi T, Ogawa W, Hirata KI: Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease. Heart Vessels, 2017; 32: 39-46","DOI":"10.1007\/s00380-016-0841-y"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest, 2007; 117: 175-184","DOI":"10.1172\/JCI29881"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Wellen KE, Hotamisligil GS: Obesity-induced inflammatory changes in adipose tissue. J Clin Invest, 2003; 112: 1785-1758","DOI":"10.1172\/JCI200320514"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Suganami T, Nishida J, Ogawa Y: A paracrine loop between adipocytes and macrophages aggravates inflam matory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol, 2005; 25: 2062-2068","DOI":"10.1161\/01.ATV.0000183883.72263.13"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Ohira H, Fujioka Y, Katagiri C, Mamoto R, Aoyama-Ishikawa M, Amako K, Izumi Y, Nishiumi S, Yoshida M, Usami M, Ikeda M: Butyrate attenuates inflammation and lipolysis generated by the interaction of adipocytes and macrophages. J Atheroscler Thromb, 2013; 20: 425-442","DOI":"10.5551\/jat.15065"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Wang X, He G, Peng Y, Zhong W, Wang Y, Zhang B: Sodium butyrate alleviates adipocyte inflammation by inhibiting NLRP3 pathway. Sci Rep, 2015; 5: 12676","DOI":"10.1038\/srep12676"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Al-Lahham SH, Roelofsen H, Priebe M, Weening D, Dijkstra M, Hoek A, Rezaee F, Venema K, Vonk RJ: Regulation of adipokine production in human adipose tissue by propionic acid. Eur J Clin Invest, 2010; 40: 401-407","DOI":"10.1111\/j.1365-2362.2010.02278.x"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Chatzigeorgiou A, Karalis KP, Bornstein SR, Chavakis T: Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia, 2012; 55: 2583-2592","DOI":"10.1007\/s00125-012-2607-0"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Shirakawa K, Yan X, Shinmura K, Endo J, Kataoka M, Katsumata Y, Yamamoto T, Anzai A, Isobe S, Yoshida N, Itoh H, Manabe I, Sekai M, Hamazaki Y, Fukuda K, Minato N, Sano M: Obesity accelerates T cell senescence in murine visceral adipose tissue. J Clin Invest, 2016; 126: 4626-4639","DOI":"10.1172\/JCI88606"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91) Cipolletta D: Adipose tissue-resident regulatory T cells: phenotypic specialization, functions and therapeutic potential. Immunology, 2014; 142: 517-525","DOI":"10.1111\/imm.12262"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92) Liu J, Divoux A, Sun J, Zhang J, Cl\u00e9ment K, Glickman JN, Sukhova GK, Wolters PJ, Du J, Gorgun CZ, Doria A, Libby P, Blumberg RS, Kahn BB, Hotamisligil GS, Shi GP: Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med, 2009; 15: 940-945","DOI":"10.1038\/nm.1994"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93) Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature, 2006; 444: 1022-1023","DOI":"10.1038\/4441022a"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94) Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, Liang S, Zhang W, Guan Y, Shen D, Peng Y, Zhang D, Jie Z, Wu W, Qin Y, Xue W, Li J, Han L, Lu D, Wu P, Dai Y, Sun X, Li Z, Tang A, Zhong S, Li X, Chen W, Xu R, Wang M, Feng Q, Gong M, Yu J, Zhang Y, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang Z, Chen H, Yang R, Zheng W, Li S, Yang H, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J: A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 2012; 490: 55-60","DOI":"10.1038\/nature11450"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95) Karlsson FH, Tremaroli V, Nookaew I, Bergstr\u00f6m G, Behre CJ, Fagerberg B, Nielsen J, B\u00e4ckhed F: Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature, 2013; 498: 99-103","DOI":"10.1038\/nature12198"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96) Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SE, MacDougall K, Preston T, Tedford C, Finlayson GS, Blundell JE, Bell JD, Thomas EL, Mt-Isa S, Ashby D, Gibson GR, Kolida S, Dhillo WS, Bloom SR, Morley W, Clegg S, Frost G: Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut, 2015; 64: 1744-1754","DOI":"10.1136\/gutjnl-2014-307913"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97) Freeland KR, Wolever TM: Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha. Br J Nutr, 2010; 103: 460-466","DOI":"10.1017\/S0007114509991863"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98) Lin HV, Frassetto A, Kowalik EJ Jr, Nawrocki AR, Lu MM, Kosinski JR, Hubert JA, Szeto D, Yao X, Forrest G, Marsh DJ: Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One, 2012; 7: e35240","DOI":"10.1371\/journal.pone.0035240"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99) De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, B\u00e4ckhed F, Mithieux G: Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell, 2014; 156: 84-96","DOI":"10.1016\/j.cell.2013.12.016"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100) Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, Petersen KF, Kibbey RG, Goodman AL, Shulman GI: Acetate mediates a microbiome-brain-\u03b2-cell axis to promote metabolic syndrome. Nature, 2016; 534: 213-217","DOI":"10.1038\/nature18309"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101) Pingitore A, Chambers ES, Hill T, Maldonado IR, Liu B, Bewick G, Morrison DJ, Preston T, Wallis GA, Tedford C, Casta\u00f1era Gonz\u00e1lez R, Huang GC, Choudhary P, Frost G, Persaud SJ: The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro. Diabetes Obes Metab, 2017; 19: 257-265","DOI":"10.1111\/dom.12811"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102) Fushimi T, Suruga K, Oshima Y, Fukiharu M, Tsukamoto Y, Goda T: Dietary acetic acid reduce serum cholesterol and triacylglycerols in rats fed a cholesterol-rich diet. Br J Nutr, 2006; 95: 916-924","DOI":"10.1079\/BJN20061740"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103) Demign\u00e9 C, Morand C, Levrat MA, Besson C, Moundras C, R\u00e9m\u00e9sy C: Effect of propionate on fatty acid and cholesterol synthesis and on acetate metabolism in isolated rat hepatocytes. Br J Nutr, 1995; 74: 209-219","DOI":"10.1079\/BJN19950124"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104) Weitkunat K, Schumann S, Nickel D, Kappo KA, Petzke KJ, Kipp AP, Blaut M, Klaus S: Importance of propionate for the repression of hepatic lipogenesis and improvement of insulin sensitivity in high-fat dietinduced obesity. Mol Nutr Food Res, 2016; 60: 2611-2621","DOI":"10.1002\/mnfr.201600305"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105) Dimova LG, Zlatkov N, Verkade HJ, Uhlin BE, Tietge UJ: High-cholesterol diet does not alter gut microbiota composition in mice. Nutr Metab (Lond), 2017; 14: 15","DOI":"10.1186\/s12986-017-0170-x"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106) Tarini J, Wolever TM: The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reducesfree-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab, 2010; 35: 9-16","DOI":"10.1139\/H09-119"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107) Woting A, Blaut M: The Intestinal Microbiota in Metabolic Disease. Nutrients, 2016; 8: 202","DOI":"10.3390\/nu8040202"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108) Bergeron N, Williams PT, Lamendella R, Faghihnia N, Grube A, Li X, Wang Z, Knight R, Jansson JK, Hazen SL, Krauss RM: Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk. Br J Nutr, 2017; 116: 2020-2029","DOI":"10.1017\/S0007114516004165"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/7\/24_RV17006\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T01:17:26Z","timestamp":1569374246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/24\/7\/24_RV17006\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":108,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv17006","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}